Cytotoxic Function of Umbilical Cord Blood Natural Killer Cells: Relevance to Adoptive Immunotherapy

REFERENCES

• Caligiuri MA. Human natural killer cells. Blood. 2008;112:461–469.
   PubMed Web of Science ®Google Scholar
• Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol. 2006;118:1–10.
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Cai SF, Cao X, Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007;26:798–811.
   PubMed Web of Science ®Google Scholar
• Diefenbach, A, Jensen ER, Jamieson AN, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature. 2001;413:165–171.
   PubMed Web of Science ®Google Scholar
• Pende D, Canton, C, Rivera P, Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol. 2001;31:1076–1086.
   PubMed Web of Science ®Google Scholar
• Moretta, A, Bottino C, Mingari MC, What is a natural killer cell? Nat Immunol. 2002;3:6–8.
   PubMed Web of Science ®Google Scholar
• Lanier LL. NK cells receptors. Annu Rev Immunol. 1998;16:359–370.
   PubMed Web of Science ®Google Scholar
• Degli-Esposti MA, Smyth MJ. Close encounters of different kinds. Dendritic cells and NK cells take centre stage. Nat Rev Immunol. 2005;5:112–124.
   PubMed Web of Science ®Google Scholar
• Robbins SH, Bessou G, Cornillon A, Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathol. 2007;3:e123.
   PubMed Web of Science ®Google Scholar
• Lopez MC, Palmer BE, Lawrence DA. Phenotypic differences between cord blood and adult peripheral blood. Cytom B Clin Cytom. 2008;76B:37–46.
   Web of Science ®Google Scholar
• Chin TW, Ank BJ, Murakami D, Cytotoxic studies in human newborns: lessened allogeneic cell-induced (augmented) cytotoxicity but strong lymphokine-activated cytotoxicity of cord mononuclear cells. Cell Immunol. 1986;103:241–251.
   PubMedGoogle Scholar
• Dalle JH, Menezes J, Wagner E, Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res. 2005;57:649–655.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Yan DC. ICAM-1 (CD54) expression on T lymphocytes and natural killer cells from umbilical cord blood: regulation with interleukin-12 and interleukin-15. Cytokines Cell Mol Ther. 2000;6:161–164.
   PubMed Web of Science ®Google Scholar
• Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res. 2003;90:127–156.
   PubMed Web of Science ®Google Scholar
• Farag SS, VanDeusen JB, Fehniger TA, Caligiuri MA. Biology and clinical impact of human natural killer cells. Int J Hematol. 2003;78:7–17.
   PubMed Web of Science ®Google Scholar
• Nguyen QH, Roberts RL, Ank BJ, Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell Immunol. 1998;185:83–92.
   PubMedGoogle Scholar
• Lin SJ, Yang MH, Chao HC, Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells. Pediatr Allergy Immunol. 2000;11:168–174.
   PubMedGoogle Scholar
• Lin SJ, Cheng PJ, Huang YJ, Kuo ML. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol. 2004;15:79–85.
   PubMedGoogle Scholar
• Webb BJ, Bochan MR, Montel A, The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol. 1994;159:246–261.
   PubMedGoogle Scholar
• Qian JX, Lee SM, Suen Y, Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood. 1997;90:3106–3117.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Kuo ML. Effect of cyclosporin-A on interleukin-15 activated umbilical cord blood natural killer cell function. Cytotherapy. 2008;10:397–405.
   PubMed Web of Science ®Google Scholar
• Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol. 2008;9:713–725.
   Google Scholar
• Orange JS, Harris KE, Andzelm MM, The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci U S A. 2003;100:14151–14156.
   PubMed Web of Science ®Google Scholar
• Inoue H, Miyaji M, Kosugi A, Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase C-gamma following CD2 stimulation. Eur J Immunol. 2002;32:2188–2198.
   PubMedGoogle Scholar
• Bryceson YT, March ME, Barber DF, Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med. 2005;202:1001–1012.
   PubMed Web of Science ®Google Scholar
• Mace EM, Monkley SJ, Critchley DR, Takei F. A dual role for talin in NK cell cytotoxicity: activation of LFA-1-mediated cell adhesion and polarization of NK cells. J Immunol. 2009;15:48–56.
   Google Scholar
• Chen X, Trivedi PP, Ge B, Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc Natl Acad Sci U S A. 2007;10:6329–6334.
   Google Scholar
• Masilamani M, Nguyen C, Kabat J, CD94/NKG2A Inhibits NK Cell Activation by disrupting the actin network at the immunological synapse. J Immunol. 2006;177:3590–3596.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Kai S, Yamaguchi M, Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur J Haematol. 2003;71:29–38.
   PubMed Web of Science ®Google Scholar
• Engelmann I, Moeller U, Santamaria A, Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population. Immunology. 2006;119:515–521.
   PubMedGoogle Scholar
• Wang Y, Xu H, Zheng X, High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol. 2007;4:377–382.
   PubMed Web of Science ®Google Scholar
• Xing D, Ramsay AG, Gribben AG, Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 ex vivo expansion. J Immunother. 2010;33:684–696.
   PubMed Web of Science ®Google Scholar
• Taga K, Yamauchi A, Kabashima K, Target-induced death by apoptosis in human lymphokine-activated natural killer cells. Blood. 1996;87:2411–2418.
   PubMed Web of Science ®Google Scholar
• Azzoni L, Anegon I, Calabretta B, Perussia B. Ligand binding to Fc gamma R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J Immunol. 1995;154:491–499.
   PubMed Web of Science ®Google Scholar
• Ida H, Anderson P. Activation-induced NK cell death triggered by CD2 stimulation. Eur J Immunol. 1998;28:1292–1300.
   PubMed Web of Science ®Google Scholar
• Poggi A, Massaro AM, Negrini S, Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J Immunol. 2005;174:2653–2660.
   PubMed Web of Science ®Google Scholar
• Berg M, Lundqvist A, McCoy P Jr, Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Cytotherapy. 2009;11:341–355.
   PubMed Web of Science ®Google Scholar
• Dominguez E, Madrigal JA, Layrisse Z, Cohen SB. Fetal natural killer cell function is suppressed. Immunology. 1998;94:109–114.
   PubMedGoogle Scholar
• Giri JG, Anderson DM, Kumaki S, IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leuk. Biol. 1995;57:763–766.
   PubMed Web of Science ®Google Scholar
• Ranson T, Vosshenrich CA, Corcuff E, IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood. 2003;101:4887–4893.
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Miyazaki T, Minami Y, IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. Ann N Y Acad Sci. 1995;766:235–244.
   PubMed Web of Science ®Google Scholar
• Lin JX, Migone TS, Tsang M, The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 1995;2:331–339.
   PubMed Web of Science ®Google Scholar
• De Totero D, Meazza R, Capaia M, The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood. 2008;111:517–524.
   PubMed Web of Science ®Google Scholar
• Kennedy MK, Glaccum M, Brown SN, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191:771–780.
   PubMed Web of Science ®Google Scholar
• Koka R, Burkett PR, Chien M, Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med. 2003;197:977–984.
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Cai SF, Cao X, Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007;26:798–811.
   PubMed Web of Science ®Google Scholar
• Huntington ND, Puthalakath H, Gunn P, Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol. 2007;8:856–863.
   PubMed Web of Science ®Google Scholar
• Nguyen QH, Roberts RL, Ank BJ, Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell Immunol. 1998;185:83–92.
   PubMedGoogle Scholar
• Choi SS, Chabra VS, Nguyen QH, Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture. Clin Diagn Lab Immunol. 2004;11:879–888.
   PubMedGoogle Scholar
• Munger W, Dejoy SQ, Jeyaseelan R, Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol. 1995;165:289–293.
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Mancusi A, Burchielli E, NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol Dis. 2008;40:84–90.
   PubMed Web of Science ®Google Scholar
• Clausen J, Wolf D, Petzer AL, Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol. 2007;148:520–528.
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Urbani E, Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–2100.
   PubMed Web of Science ®Google Scholar
• Willemze R, Rodrigues CA, Labopin M, et al; Eurocord-Netcord and Acute Leukaemia Working Party of the EBMT. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009;23:492–500.
   PubMed Web of Science ®Google Scholar
• Passweg JR, Stern M, Koehl U, Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant. 2005;35:637–643.
   PubMed Web of Science ®Google Scholar
• Fauriat C, Just-Landi S, Mallet F, Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood. 2007;109:323–330.
   PubMed Web of Science ®Google Scholar
• Savani BN, Rezvani K, Mielke S, Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood. 2006;107:1688–1695.
   PubMed Web of Science ®Google Scholar
• Dunbar EM, Buzzeo MP, Levine JB, The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica. 2008;93:1852–1858.
   PubMed Web of Science ®Google Scholar
• Lundqvist A, McCoy JP, Samsel L, Childs R. Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors. Blood. 2007;109:3603–3606.
   PubMed Web of Science ®Google Scholar
• Miller JS, Soignier Y, Panoskaltsis-Mortari A, Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105:3051–3057.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Rooney CM, Heslop HE. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant. 2008;41:193–198.
   PubMed Web of Science ®Google Scholar
• Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood. 1998;92:11–18.
   PubMed Web of Science ®Google Scholar
• Mazur MA, Davis CC, Szabolcs P. Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation. Biol Blood Marrow Transplant. 2008;14:1190–1196.
   PubMed Web of Science ®Google Scholar
• Nagamura-Inoue T, Mori Y, Yizhou Z, Differential expansion of umbilical cord blood mononuclear cell-derived natural killer cells dependent on the dose of interleukin-15 with Flt3L. Exp Hematol. 2004;32:202–209.
   PubMed Web of Science ®Google Scholar
• Perez SA, Mahaira LG, Demirtzoglou FJ, A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival. Blood. 2005;106:158–166.
   PubMedGoogle Scholar
• Robinson KL, Ayello J, Hughes R, Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7: potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. Exp Hematol. 2002;30:245–251.
   PubMed Web of Science ®Google Scholar
• Condiotti R, Zakai YB, Barak V, Nagler A. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Exp Hematol. 2001;29:104–113.
   PubMed Web of Science ®Google Scholar
• Imai C, Iwamoto S, Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood. 2005;106:376–383.
   PubMed Web of Science ®Google Scholar